Reckitt Benckiser (RB/ LN, BUY, T/P 9000p) released their full year results this morning beating on both EPS and revenue. Sales for the full year increased 11.5% to £9,891m beating consensus forecast of £9,863m. EPS was at the top end of the range at 302p (vs 296p).
10 Feb 2017
$17bn For Mead Johnson Confirmed – +1% OSG in Q4
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
$17bn For Mead Johnson Confirmed – +1% OSG in Q4
Reckitt Benckiser Group plc (RKT:LON) | 4,160 1164.9 0.7% | Mkt Cap: 29,395m
- Published:
10 Feb 2017 -
Author:
Chris Wickham -
Pages:
4
Reckitt Benckiser (RB/ LN, BUY, T/P 9000p) released their full year results this morning beating on both EPS and revenue. Sales for the full year increased 11.5% to £9,891m beating consensus forecast of £9,863m. EPS was at the top end of the range at 302p (vs 296p).